TickerFactsScreenerDevelopers

Dare Bioscience, Inc. (DARE) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2011: $15.35M2012: $16.71M2013: $5.49M2014: $51.17M2015: $219.4K2016: $44.6K2017: $7.56M2018: $6.81M2019: $4.78M2020: $4.67M2021: $51.67M2022: $34.67M2023: $10.48M2024: $15.70M2025: $24.71M$24.71M
2011Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$24.71M+57.4%
2024$15.70M+49.8%
2023$10.48M-69.8%
2022$34.67M-32.9%
2021$51.67M+1006.6%
2020$4.67M-2.3%
2019$4.78M-29.8%
2018$6.81M-10.0%
2017$7.56M+16845.0%
2016$44.6K-79.7%
2015$219.4K-99.6%
2014$51.17M+832.5%
2013$5.49M-67.2%
2012$16.71M+8.9%
2011$15.35M—